Overview of NICE’s Elranatamab Managed Ac...

By João L. Carapinha

October 29, 2024

NICE recently recommended Elranatamab as an option for treating relapsed and refractory multiple myeloma in adults with a man...
Ozempic Shows Promise in Reducing Alzheimer’s Risk
Neoadjuvant Chemotherapy: Transforming Treatment for Advanced Ovarian Cancer
Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Telemedicine Growth in the MENA Region: A Digital Healthcare Revolution
Saudi Healthcare Reform: Vision 2030 and Beyond
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
Rising Hearing Loss in Africa by 2030: Urgent Measures Needed